SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
EFFECTS OF DRUG DISPOSITION IN THE CSF, LYMPH NODES, LUNG, AND GENITAL TRACT
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
TOTAL AND UNBOUND DORAVIRINE CONCENTRATIONS AND VIRAL SUPPRESSION IN CSF OF HIV+ PTS (ABSTRACT
358)
Juan M Tiraboschi
Hospital Universitari de Bellvitge, Barcelona, Spain
PERSISTENT HIV TRANSCRIPTION AND VARIABLE ARV LEVELS IN LYMPH NODES DURING ART (ABSTRACT
359)
Courtney V Fletcher
University of Nebraska Medical Center, Omaha, NE, USA
PBPK MODELS OF TFV EXPOSURE IN LYMPH NODES REVEAL PERMEABILITY-LIMITED DISTRIBUTION (ABSTRACT
360)
Erin M.B. Scholz
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF TFV AND TAF FOR PREP IN FORESKIN TISSUE (ABSTRACT
361)
Carolina Herrera
Imperial College London, London, United Kingdom
DORAVIRINE CONCENTRATIONS AND HIV-1 RNA SUPPRESSION IN MALE AND FEMALE GENITAL FLUIDS (ABSTRACT
362)
Sofia Scevola
Hospital Universitari de Bellvitge, Barcelona, Spain
PREDICTED SUCCESS OF PREP USERS' PREFERRED NONDAILY TENOFOVIR/EMTRICITABINE REGIMENS (ABSTRACT
363)
Julie B Dumond
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
HIGH LUNG LEVELS OF ACTIVE TRIPHOSPHATE PREDICTED WITH ORAL AT-527 IN COVID PATIENTS (ABSTRACT
364)
Xiao-Jian Zhou
Atea Pharmaceuticals, Inc., Boston, MA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
